Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang Hak Han

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Frontiers in Microbiology|March 20, 2023
<i>Bifidobacterium</i>-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axisSang Jun Yoon, Jeong Seok Yu, Byeong Hyun Min, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|February 2, 2013
Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of ratSo Hyung Hong, Ki Tae Suk, Sang Hyeon Choi, et al.
Frontiers in Microbiology|June 19, 2023
Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in ratsJin-Ju Jeong, Raja Ganesan, Yoo-Jeong Jin, et al.
Probiotics and Antimicrobial Proteins|March 12, 2024
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin PathwayJin-Ju Jeong, Yoo-Jeong Jin, Raja Ganesan, et al.
Gut Microbes|January 23, 2020
<i>Lactobacillus</i> and <i>Pediococcus</i> ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiomeNa Young Lee, Sang Jun Yoon, Dae Hee Han, et al.
Gut Microbes|February 1, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammationByeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Clinical and Translational Medicine|December 29, 2021
Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver diseaseJeong Seok Yu, Gi Soo Youn, Jieun Choi, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Frontiers in Microbiology|March 20, 2023
<i>Bifidobacterium</i>-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axisSang Jun Yoon, Jeong Seok Yu, Byeong Hyun Min, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|February 2, 2013
Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of ratSo Hyung Hong, Ki Tae Suk, Sang Hyeon Choi, et al.
Frontiers in Microbiology|June 19, 2023
Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in ratsJin-Ju Jeong, Raja Ganesan, Yoo-Jeong Jin, et al.
Probiotics and Antimicrobial Proteins|March 12, 2024
Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin PathwayJin-Ju Jeong, Yoo-Jeong Jin, Raja Ganesan, et al.
Gut Microbes|January 23, 2020
<i>Lactobacillus</i> and <i>Pediococcus</i> ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiomeNa Young Lee, Sang Jun Yoon, Dae Hee Han, et al.
Gut Microbes|February 1, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammationByeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Clinical and Translational Medicine|December 29, 2021
Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver diseaseJeong Seok Yu, Gi Soo Youn, Jieun Choi, et al.
Pageof 4